<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<title>Insert title here</title>
<link rel="stylesheet" type="text/css" href="css/bootstrap.min.css">
<link rel="stylesheet" type="text/css" href="css/bootstrap-theme.min.css">
<link rel="stylesheet" type="text/css" href="css/main.css">
<link rel="stylesheet" href="js/jstree/themes/default/style.min.css" />
<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/jquery-ui-1.10.4.min.js"></script>
<script type="text/javascript" src="js/bootstrap.min.js"></script>
<script type="text/javascript" src="js/spin.min.js"></script>
<script type="text/javascript" src="js/main.js"></script>
<script src="http://yui.yahooapis.com/3.16.0/build/yui/yui-min.js"></script>
<script type="text/javascript" src="js/jstree/jstree.min.js"></script>
</head>
<body>

	<div class="container">
		<h2 class="page-header">Clinical Trials <span class="glyphicon glyphicon-search"></span></h2>
		<p class="lead">Matching clinical trials</p>
		<div class="row well">
			<ol>
				<li><a href="javascript:void(0)" onclick="getPublicationDetails(this)">NCT01827163</a><br><small>Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer.</small>
					<p><small><i>Status: Active, not recruiting</i></small></p>
					<p><small><i>Interventions: Drug: Paclitaxel;   Drug: Trastuzumab;   Drug: Lapatinib;   Drug: Pegfilgrastim</i></small></p>
					<p><b>Score: </b>45%</p>
				</li>
				<li><a href="javascript:void(0)" onclick="getPublicationDetails(this)">NCT00486668</a><br><small>A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer</small>
					<p><small><i>Status: Active, not recruiting</i></small></p>
					<p><small><i>Interventions: Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: trastuzumab;   Drug: lapatinib</i></small></p>
					<p><b>Score: </b>32%</p>
				</li>
				<li><a href="javascript:void(0)" onclick="getPublicationDetails(this)">NCT01133912</a><br><small>Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb) (PGT)</small>
					<p><small><i>Status: Completed</i></small></p>
					<p><small><i>Interventions:	Drug: paclitaxel, gemcitabine, lapatinib</i></small></p>
					<p><b>Score: </b>28%</p>
				</li>
				<li><a href="javascript:void(0)" onclick="getPublicationDetails(this)">NCT01730677</a><br><small>Lapatinib plus capecitabine for HER2-positive advanced breast cancer.</small>
					<p><small><i>Status: Recruiting</i></small></p>
					<p><small><i>Interventions:	Drug: Lapatinib;   Drug: Vinorelbine</i></small></p>
					<p><b>Score: </b>15%</p>
				</li>
				
			</ol>
		</div>
		<div class="row"><button class="btn btn-primary">Recommend therapy</button></div>
	</div>
</body>
</html>